Interleukin 2 and systemic lupus erythematosus. Beyond the transcriptional regulatory net abnormalities

Autoimmunity Reviews

Volumn 9, Issue 1, 2009, Pages 34-39

  Gómez Martín, Diana ^a   Díaz Zamudio, Mariana ^a   Crispín, José Carlos ^b   Alcocer Varela, Jorge ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CREB; CREM; IL 2; Systemic lupus erythematosus; Transcriptional regulation

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; INTERLEUKIN 2; PHOSPHATASE; PROTEIN C FOS;

CELL DEATH; DISEASE COURSE; GENE CONTROL; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT MODULATOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; EPIGENESIS, GENETIC; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 69649083354     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.02.035     Document Type: Review

References (40)

1. Brandhuber B.J., Boone T., Keeney W.C., and McKay D.B. Three-dimensional structure of interleukin-2. Science 238 (1987) 1707-1709
2. Malek T.R. The biology of interleukin-2. Annu Rev Immunol 26 (2008) 453-479
3. Powell J.D., Ragheb J.A., Kitagawa-Sakakida S., and Schwartz R.H. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol Rev 165 (1998) 287-300
4. Stauber D.J., Debler E.W., Horton P.A., Smith K.A., and Wilson I.A. Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. Proc Natl Acad Sci U S A 103 (2006) 2788-2793
5. Williams M.A., Tyznik A.J., and Bevan M.J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 441 (2006) 890-893
6. Refaeli Y., Van Parijs L., London C.A., Tschopp J., and Abbas A.K. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8 (1998) 615-623
7. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
8. Gong D., and Malek T.R. Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production. J Immunol 178 (2007) 242-252
9. Martins G.A., Cimmino L., Shapiro-Shelef M., Szabolcs M., Herron A., Magnusdottir E., et al. Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol 7 (2006) 457-465
10. Solomou E.E., Juang Y.T., Gourley M.F., Kammer G.M., and Tsokos G.C. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J Immunol 166 (2001) 4216-4222
11. Suzuki H., Kundig T.M., Furlonger C., Wakeham A., Timms E., Matsuyama T., Schmits R., Simard J.J., Ohashi P.S., Griesser H., et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268 (1995) 1472-1476
12. Drappa J., Kamen L.A., Chan E., Georgiev M., Ashany D., Marti F., et al. Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice. J Exp Med 198 (2003) 809-821
13. La Cava A. T-regulatory cells in systemic lupus erythematosus. Lupus 17 (2008) 421-425
14. Vargas-Rojas M.I., Crispin J.C., Richaud-Patin Y., and Alcocer-Varela J. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 17 (2008) 289-294
15. Altman A., Theofilopoulos A.N., Weiner R., Katz D.H., and Dixon F.J. Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J Exp Med 154 (1981) 791-808
16. Alcocer-Varela J., and Alarcon-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 69 (1982) 1388-1392
17. Murakawa Y., and Sakane T. Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition of phorbol myristate acetate. Arthritis Rheum 31 (1988) 826-833
18. Linker-Israeli M., Bakke A.C., Quismorio F.P., and Horwitz D.A. Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest 75 (1985) 762-768
19. Alcocer-Varela J., and Alarcon-Segovia D. Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosus. Rheumatol Int 15 (1995) 57-63
20. Fujii Y., Fujii K., and Tanaka Y. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients. Autoimmun Rev 5 (2006) 143-144
21. Katsiari C.G., and Tsokos G.C. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus. Autoimmun Rev 5 (2006) 118-121
22. Kyttaris V.C., and Tsokos G.C. T lymphocytes in systemic lupus erythematosus: an update. Curr Opin Rheumatol 16 (2004) 548-552
23. Liossis S.N., Ding X.Z., Dennis G.J., and Tsokos G.C. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest 101 (1998) 1448-1457
24. Krishnan S., Warke V.G., Nambiar M.P., Tsokos G.C., and Farber D.L. The FcR gamma subunit and Syk kinase replace the CD3 zeta-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. J Immunol 170 (2003) 4189-4195
25. Krishnan S., Nambiar M.P., Warke V.G., Fisher C.U., Mitchell J., Delaney N., et al. Alterations in lipid raft composition and dynamics contribute to abnormal T cell responses in systemic lupus erythematosus. J Immunol 172 (2004) 7821-7831
26. Nambiar M.P., Fisher C.U., Warke V.G., Krishnan S., Mitchell J.P., Delaney N., et al. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum 48 (2003) 1948-1955
27. Juang Y.T., Wang Y., Jiang G., Peng H.B., Ergin S., Finnell M., et al. PP2A dephosphorylates Elf-1 and determines the expression of CD3zeta and FcRgamma in human systemic lupus erythematosus T cells. J Immunol 181 (2008) 3658-3664
28. Takeuchi T., Tsuzaka K., Pang M., Amano K., Koide J., and Abe T. TCR zeta chain lacking exon 7 in two patients with systemic lupus erythematosus. Int Immunol 10 (1998) 911-921
29. Tsuzaka K., Setoyama Y., Yoshimoto K., Shiraishi K., Suzuki K., Abe T., et al. A splice variant of the TCR zeta mRNA lacking exon 7 leads to the down-regulation of TCR zeta, the TCR/CD3 complex, and IL-2 production in systemic lupus erythematosus T cells. J Immunol 174 (2005) 3518-3525
30. Nambiar M.P., Enyedy E.J., Fisher C.U., Krishnan S., Warke V.G., Gilliland W.R., et al. Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus. Arthritis Rheum 46 (2002) 163-174
31. Kyttaris V.C., Wang Y., Juang Y.T., Weinstein A., and Tsokos G.C. Increased levels of NF-ATc2 differentially regulate CD154 and IL-2 genes in T cells from patients with systemic lupus erythematosus. J Immunol 178 (2007) 1960-1966
32. Tenbrock K., Juang Y.T., Gourley M.F., Nambiar M.P., and Tsokos G.C. Antisense cyclic adenosine 5′-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J Immunol 169 (2002) 4147-4152
33. Tenbrock K., Juang Y.T., Tolnay M., and Tsokos G.C. The cyclic adenosine 5′-monophosphate response element modulator suppresses IL-2 production in stimulated T cells by a chromatin-dependent mechanism. J Immunol 170 (2003) 2971-2976
34. Kyttaris V.C., Kyttaris V.C., Juang Y.T., Tenbrock K., Weinstein A., and Tsokos G.C. Cyclic adenosine 5′-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus. J Immunol 173 (2004) 3557-3563
35. Juang Y.T., Wang Y., Solomou E.E., Li Y., Mawrin C., Tenbrock K., et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J Clin Invest 115 (2005) 996-1005
36. Katsiari C.G., Kyttaris V.C., Juang Y.T., and Tsokos G.C. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J Clin Invest 115 (2005) 3193-3204
37. Kammer G.M., Khan I.U., and Malemud C.J. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J Clin Invest 94 (1994) 422-430
38. Khan I.U., Laxminarayana D., and Kammer G.M. Protein kinase A RI beta subunit deficiency in lupus T lymphocytes: bypassing a block in RI beta translation reconstitutes protein kinase A activity and augments IL-2 production. J Immunol 166 (2001) 7600-7605
39. Mishra N., Khan I.U., Tsokos G.C., and Kammer G.M. Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes. J Immunol 165 (2000) 2830-2840
40. Elliott M.R., Tolnay M., Tsokos G.C., and Kammer G.M. Protein kinase A regulatory subunit type II beta directly interacts with and suppresses CREB transcriptional activity in activated T cells. J Immunol 171 (2003) 3636-3644